(Q45893042)

17 December 2017

title

Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation (English)

1 reference

17 December 2017

1 reference

Michael H Kim

1

1 reference

17 December 2017

David Klingman

2

1 reference

17 December 2017

Jay Lin

3

1 reference

17 December 2017

Prathamesh Pathak

4

1 reference

17 December 2017

David S Battleman

5

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

17 December 2017

Annals of Pharmacotherapy

published in

1 reference

17 December 2017

volume

43

1 reference

17 December 2017

page(s)

840-848

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

cites work

1 reference

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

21 January 2018

1 reference

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

21 January 2018

1 reference

ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the P

21 January 2018

1 reference

Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation

21 January 2018

1 reference

Quality of life in patients with atrial fibrillation: a systematic review

21 January 2018

1 reference

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group

21 January 2018

1 reference

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

21 January 2018

1 reference

Amiodarone versus sotalol for atrial fibrillation

21 January 2018

1 reference

Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias

21 January 2018

1 reference

Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitals.

21 January 2018

1 reference

Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database

21 January 2018

1 reference

Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry.

21 January 2018

1 reference

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.

21 January 2018

1 reference

Economic burden and co-morbidities of atrial fibrillation in a privately insured population.

21 January 2018

1 reference

The costs of care in atrial fibrillation and the effect of treatment modalities in Germany

21 January 2018

1 reference

Impact of atrial fibrillation on mortality, stroke, and medical costs

21 January 2018

1 reference

Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1L698

1 reference

17 December 2017

PubMed ID

19417111

1 reference

17 December 2017